Unknown NA INTERVENTIONAL 2-arm NCT00655330

Probucol Combined With Valsartan in Reducing Proteinuria in Diabetes Nephropathy

A Prospective Randomized, Controlled, Open-labeled Trial of Probucol Combined With Valsartan in Patients With Diabetes Nephropathy

Sponsor: Guangdong Provincial People's Hospital

Conditions Nephropathy Type 2 Diabetes Mellitus

Interventions Placebo Probucol Valsartan

Updated 7 times since 2017 Last updated: Aug 23, 2016 Started: May 31, 2008 Primary completion: May 31, 2017 Completion: May 31, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Nephropathy and Type 2 Diabetes Mellitus, this trial is ongoing. The trial is conducted by Guangdong Provincial People's Hospital and has accumulated 7 data snapshots since 2008. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status NA
Dec 2019 — Jan 2021 [monthly]

Unknown Status NA
Sep 2018 — Dec 2019 [monthly]

Unknown Status NA

Status: Active Not Recruiting → Unknown Status

▶ Show 2 earlier versions

Jun 2018 — Sep 2018 [monthly]

Active Not Recruiting NA
Jan 2017 — Jun 2018 [monthly]

Active Not Recruiting NA

First recorded

May 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Guangdong Provincial People's Hospital

Data source: Guangdong Provincial People's Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Guangzhou, China